{"url":"https://etfiq.com/holdings/tbph/","section":"holdings","title":"ETFs That Hold Theravance Biopharma Inc (TBPH) | ETFIQ","description":"24 thematic and core ETFs hold Theravance Biopharma Inc (TBPH). BBP holds the most, at 1.40% of the fund on Jul 31, 2026.","as_of":"Nov 21, 2026","structured_data":[{"@type":"Dataset","@id":"https://etfiq.com/holdings/tbph#data","name":"ETFs holding Theravance Biopharma Inc","description":"Every US listed ETF that holds Theravance Biopharma Inc, with each fund\u2019s published weight and filing date.","creator":{"@id":"https://etfiq.com/#org"},"isAccessibleForFree":true,"variableMeasured":["Share of fund","Holdings filing date"],"license":"https://etfiq.com/license/","publisher":{"@id":"https://etfiq.com/#org"},"inLanguage":"en","creativeWorkStatus":"Published","distribution":[{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/alternatives.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/core.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/crypto.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/funds.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/income.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/leverage.json"},{"@type":"DataDownload","encodingFormat":"application/json","contentUrl":"https://etfiq.com/data/thematic.json"}]},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Which ETFs hold Theravance Biopharma Inc?","acceptedAnswer":{"@type":"Answer","text":"24 thematic and core ETFs hold Theravance Biopharma Inc, by holdings dated Jun 30, 2026 to Aug 31, 2026. The largest positions are BBP at 1.40% of the fund on Jul 31, 2026, JSML at 0.61% of the fund on Jul 31, 2026 and SBIO at 0.45% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"ETFIQ","item":"https://etfiq.com/"},{"@type":"ListItem","position":2,"name":"Holdings","item":"https://etfiq.com/holdings/"},{"@type":"ListItem","position":3,"name":"Theravance Biopharma Inc","item":"https://etfiq.com/holdings/tbph/"}]},{"@type":"WebPage","name":"ETFs That Hold Theravance Biopharma Inc (TBPH)","description":"24 thematic and core ETFs hold Theravance Biopharma Inc (TBPH). BBP holds the most, at 1.40% of the fund on Jul 31, 2026.","url":"https://etfiq.com/holdings/tbph/","dateModified":"2026-11-19","isPartOf":{"@type":"WebSite","name":"ETFIQ","url":"https://etfiq.com"},"speakable":{"@type":"SpeakableSpecification","cssSelector":[".lede",".faq"]},"publisher":{"@id":"https://etfiq.com/#org"}}],"characters":3935,"truncated":false,"content":"ETFIQ / Holdings / Theravance Biopharma Inc \n \n ETFs that hold Theravance Biopharma Inc\n 24 thematic and core ETFs hold Theravance Biopharma Inc , by holdings dated Jun 30, 2026 to Aug 31, 2026 . BBP holds the most, at 1.40% of the fund on Jul 31, 2026 . The next largest are JSML (0.61%) and SBIO (0.45%). \n 1 income and other fund on it is listed below. 25 ETFs hold its shares in all, the number the holdings hub ranks.\n Thematic and core funds that hold it\n Fund Name Share of the fund Holdings filed Asset \n BBP Virtus Biotech ETF 1.40% Jul 31, 2026 Equity \n JSML Janus Henderson Small Cap Growth Alpha ETF 0.61% Jul 31, 2026 Equity \n SBIO ALPS Medical Breakthroughs ETF 0.45% Aug 31, 2026 Equity \n AGNG Global X Aging Population ETF 0.29% Aug 31, 2026 Equity \n GSSC GS ActiveBeta U.S. Small Cap Equity ETF 0.11% Aug 31, 2026 Equity \n FSML FRANKLIN SMALL CAP ENHANCED ETF 0.07% Jun 30, 2026 Equity \n FSMD Fidelity Small-Mid Multifactor ETF 0.07% Jul 31, 2026 Equity \n FLQS Franklin U.S. Small Cap Multifactor Index ETF 0.06% Jun 30, 2026 Equity \n FEAC Fidelity Enhanced U.S. All-Cap Equity ETF 0.05% Jun 30, 2026 Equity \n KBFR Innovator U.S. Small Cap Managed 10 Buffer ETF 0.05% Jul 31, 2026 Equity \n NUSC Nuveen ESG Small-Cap ETF 0.05% Jul 31, 2026 Equity \n PSC Principal U.S. Small-Cap ETF 0.04% Jun 30, 2026 Equity \n RESM Columbia Research Enhanced Small Cap ETF 0.04% Jun 30, 2026 Equity \n FESM Fidelity Enhanced Small Cap Core ETF 0.03% Jun 30, 2026 Equity \n RSSL Global X Russell 2000 ETF 0.02% Jul 31, 2026 Equity \n SCHA Schwab U.S. Small-Cap ETF 0.01% Aug 31, 2026 Equity \n ISCB 0.01% Jul 31, 2026 Equity \n FHLC Fidelity MSCI Health Care Index ETF 0.01% Jul 31, 2026 Equity \n DXUV US Vector Equity Portfolio ETF Class Shares 0.01% Jul 31, 2026 Equity \n MSSM Morgan Stanley Pathway Small-Mid Cap Equity ETF Aug 31, 2026 Equity \n TILT Northern Trust Morningstar US Market Factor Tilt ETF Jul 31, 2026 Equity \n DFAC U.S. Core Equity 2 Portfolio ETF Class Shares Jul 31, 2026 Equity \n DFAS U.S. Small Cap Portfolio: ETF Class Shares Jul 31, 2026 Equity \n SCHB Schwab U.S. Broad Market ETF Aug 31, 2026 Equity \n Income and other funds that hold it\n Fund Name Share of the fund Holdings filed Category \n ITWO ProShares Russell 2000 High Income ETF 0.02% Aug 31, 2026 Income \n What this counts\n Theravance Biopharma Inc (ticker TBPH, listed in KY) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund\u2019s N-PORT asset type. A fund holding only the company\u2019s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.\n Each row shows the date the fund last filed.\n Look up another company .\n Questions people ask\n Which ETFs hold Theravance Biopharma Inc? 24 thematic and core ETFs hold Theravance Biopharma Inc, by holdings dated Jun 30, 2026 to Aug 31, 2026. The largest positions are BBP at 1.40% of the fund on Jul 31, 2026, JSML at 0.61% of the fund on Jul 31, 2026 and SBIO at 0.45% of the fund on Aug 31, 2026. 1 income and other fund on it is listed apart. \n Cite this page. ETFIQ, ETFs holding Theravance Biopharma Inc, data as of Nov 21, 2026. https://etfiq.com/holdings/tbph/ Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data .\n Other forms Plain ETFIQ, ETFs holding Theravance Biopharma Inc, data as of Nov 21, 2026. https://etfiq.com/holdings/tbph/ APA ETFIQ. (Nov 21, 2026). ETFs holding Theravance Biopharma Inc. Retrieved from https://etfiq.com/holdings/tbph/ Markdown [ETFs holding Theravance Biopharma Inc (ETFIQ, Nov 21, 2026)](https://etfiq.com/holdings/tbph/)","source":"ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.","publisher":{"@id":"https://etfiq.com/#org","name":"ETFIQ","url":"https://etfiq.com"},"license":"https://etfiq.com/license/","license_text":"Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.","citation":"ETFIQ, ETFs holding Theravance Biopharma Inc, data as of Nov 21, 2026. https://etfiq.com/holdings/tbph/"}